Serum Beta 2-Microglobulin as a Biomarker of Activity in Ulcerative Colitis

Serum Amyloid A as a Biomarker of Ulcerative Colitis Disease Activity

Serum IL-22 as a Novel Non-Invasive Biomarker in Diagnosis and Assessment of Activity in Ulcerative Colitis Patients

Serum Resistin Level as a Novel Marker of Disease Activity in Patients with Ulcerative Colitis

Osteoprotegerin, Soluble Receptor Activator Nuclear Factor-κB Ligand, Nuclear Factor Kappa B and Intestinal Trefoil Factor 3 are Promising Biomarkers in Diagnosis and Follow- up

Serum activin-A as a potential biomarker for early stage ulcerative colitis (UC): An immunological and molecular evaluation study using murine animal model

OSTEOPROTEGERIN (OPG) AND SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND (S-RANKL) IN PATIENTS WITH RHEUMATOID ARTHRITIS

Evaluation of Serum Amyloid (A) Level in Ulcerative Colitis as a new Predictor of Disease Activity

Interleukin-23 as a Predictor of Activities in Inflammatory Bowel Disease

Serum Calprotectin: A promising Biomarker for Inflammatory Bowel Disease [IBD]